Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (288)
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,529,491
Price
$3.28
Total Value
$8.29M
Shares Held After
10,265,297
% of Holdings
19.8%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,634,506
Price
$3.28
Total Value
$8.64M
Shares Held After
12,666,731
% of Holdings
17.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
600
Price
$41.77
Total Value
$25.06K
Shares Held After
183,316
% of Holdings
0.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,231
Price
$40.88
Total Value
$172.96K
Shares Held After
183,916
% of Holdings
2.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,477
Price
$40.29
Total Value
$502.70K
Shares Held After
188,147
% of Holdings
6.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,692
Price
$39.14
Total Value
$496.76K
Shares Held After
200,624
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$571.61
Total Value
$114.32K
Shares Held After
45,172
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
710
Price
$569.61
Total Value
$404.42K
Shares Held After
45,372
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
690
Price
$568.79
Total Value
$392.47K
Shares Held After
46,082
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,403
Price
$567.55
Total Value
$796.27K
Shares Held After
46,772
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,629
Price
$566.66
Total Value
$923.10K
Shares Held After
48,175
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
543
Price
$565.66
Total Value
$307.15K
Shares Held After
49,804
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,115
Price
$564.55
Total Value
$629.48K
Shares Held After
50,347
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
371
Price
$563.58
Total Value
$209.09K
Shares Held After
51,462
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
774
Price
$562.34
Total Value
$435.25K
Shares Held After
51,833
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
351
Price
$561.69
Total Value
$197.15K
Shares Held After
52,607
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
514
Price
$560.30
Total Value
$287.99K
Shares Held After
52,958
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
6,193
Price
$74.05
Total Value
$458.61K
Shares Held After
16,348
% of Holdings
27.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.60
Total Value
$278.28K
Shares Held After
447,202
% of Holdings
4.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.24
Total Value
$124.15K
Shares Held After
26,453
% of Holdings
23.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,200
Price
$64.89
Total Value
$272.53K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,800
Price
$64.06
Total Value
$1.01M
Shares Held After
771,980
% of Holdings
2.0%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Erasca, Inc. (ERAS)
Garner Ebun — Chief Legal Officer
Shares
80,000
Price
$16.40
Total Value
$1.31M
Shares Held After
25,076
% of Holdings
76.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,500
Price
$2.20
Total Value
$7.70K
Shares Held After
29,375
% of Holdings
10.6%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,625
Price
$2.21
Total Value
$12.41K
Shares Held After
11,375
% of Holdings
33.1%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
300
Price
$30.34
Total Value
$9.10K
Shares Held After
12,965
% of Holdings
2.3%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,200
Price
$29.32
Total Value
$64.51K
Shares Held After
13,265
% of Holdings
14.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
300
Price
$31.07
Total Value
$9.32K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,348
Price
$30.06
Total Value
$100.64K
Shares Held After
300
% of Holdings
91.8%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
11,352
Price
$29.24
Total Value
$331.95K
Shares Held After
3,648
% of Holdings
75.7%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
162,517
Price
$3.80
Total Value
$617.40K
Shares Held After
12,794,788
% of Holdings
1.3%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
169,265
Price
$3.80
Total Value
$643.04K
Shares Held After
15,301,237
% of Holdings
1.1%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
2,500
Price
$12.95
Total Value
$32.38K
Shares Held After
119,010
% of Holdings
2.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
2,216
Price
$75.95
Total Value
$168.31K
Shares Held After
11,014
% of Holdings
16.7%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
20,105
Price
$75.50
Total Value
$1.52M
Shares Held After
13,230
% of Holdings
60.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
159
Price
$204.26
Total Value
$32.48K
Shares Held After
42,253
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
43
Price
$202.91
Total Value
$8.73K
Shares Held After
42,412
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
79
Price
$202.42
Total Value
$15.99K
Shares Held After
42,455
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
40
Price
$201.24
Total Value
$8.05K
Shares Held After
42,534
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
146
Price
$199.97
Total Value
$29.20K
Shares Held After
42,574
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.45
Total Value
$275.42K
Shares Held After
451,540
% of Holdings
4.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
337
Price
$204.50
Total Value
$68.92K
Shares Held After
41,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
963
Price
$203.22
Total Value
$195.70K
Shares Held After
41,719
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$201.90
Total Value
$141.33K
Shares Held After
42,682
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,238
Price
$200.94
Total Value
$248.77K
Shares Held After
43,382
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,302
Price
$199.72
Total Value
$260.04K
Shares Held After
44,620
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$198.85
Total Value
$91.47K
Shares Held After
45,922
% of Holdings
1.0%
Showing 1–50 of 288 transactions (page 1 of 6)